Holen Sie sich die Stockscreener-App
4.30
1.24%
0.0528
Schlusskurs vom Vortag:
$4.2472
Offen:
$4.485
24-Stunden-Volumen:
9,273
Relative Volume:
0.52
Marktkapitalisierung:
$8.68M
Einnahmen:
$5.27M
Nettoeinkommen (Verlust:
$-7.98M
KGV:
-6.0657
EPS:
-0.7089
Netto-Cashflow:
$-7.04M
1W Leistung:
-0.92%
1M Leistung:
+6.17%
6M Leistung:
+8.59%
1J Leistung:
+8.31%
1-Tages-Spanne:
$4.24
$4.485
1-Wochen-Bereich:
$4.13
$4.60
52-Wochen-Spanne:
$2.66
$4.73
Neurometrix Inc Stock (NURO) Company Profile
Firmenname
Neurometrix Inc
Sektor
Branche
Telefon
(781) 890-9989
Adresse
1000 WINTER STREET, WALTHAM
Vergleichen Sie NURO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NURO
Neurometrix Inc
|
4.30 | 8.68M | 5.27M | -7.98M | -7.04M | -0.7089 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Neurometrix Inc Stock (NURO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-10-20 | Bestätigt | H.C. Wainwright | Buy |
| 2016-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-09-11 | Eingeleitet | Maxim Group | Buy |
| 2012-02-27 | Eingeleitet | Dawson James | Buy |
Neurometrix Inc Aktie (NURO) Neueste Nachrichten
NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth - MSN
NeuroMetrix (NASDAQ:NURO) Now Covered by Analysts at StockNews.com - Defense World
NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com - Defense World
NeuroMetrix revenue down 51% in Q3 2024 - Medical Buyer
NeuroMetrix revenue increases 50% to USD 184,000 in Q3 2024 - Medical Buyer
NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023) - Yahoo Finance
NeuroMetrix Q3 2024: Mixed Results Amid Strategic Review - TipRanks
NeuroMetrix Reports Q3 2024 Business Highlights - The Manila Times
NeuroMetrix Q3 Revenue Falls 51% Despite Quell Growth; Cost-Cutting Efforts Show Promise | NURO Stock News - StockTitan
NeuroMetrix (NASDAQ:NURO) Earns Sell Rating from Analysts at StockNews.com - Defense World
NeuroMetrix stock touches 52-week high at $4.73 - Investing.com India
NeuroMetrix stock touches 52-week high at $4.73 By Investing.com - Investing.com UK
StockNews.com Initiates Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
NeuroMetrix (NASDAQ:NURO) Stock Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Neuromuscular Electrical Muscle Stimulator Industry likely to thriving future growth - Elektrotransports.lv
Transcutaneous Electrical Nerve Muscle Stimulation Industry Size, Status and Business Outlook - Elektrotransports.lv
Interferential Muscle Stimulator Industry Report By Type, Application and Geography - Elektrotransports.lv
Diabetic Neuropathy Market May See a Big Move | Cephalon, GlaxoSmithKline, NeuroMetrix - openPR
NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com - Defense World
Financial Analysis: NeuroMetrix (NASDAQ:NURO) versus Sensus Healthcare (NASDAQ:SRTS) - Defense World
NeuroMetrix Inc. | RapidScan | Dec 2006 - Photonics.com
Muscle Stimulator Market Size, Share, Growth Insights - openPR
NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com - Defense World
Internal Neuromodulation Devices Market Size, Trends And Forecast 2024-2033 - WhaTech
One Point One Solutions shares gain as company expands healthcare verticalCheck details - MSN
Rhumbline Advisers Grows Stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World
Kalikesh Singh wins NRAI President election; onus on him to take shooting to next level - RevSportz
Kalikesh Narayan Singh Deo elected NRAI President - IndianShooting.com
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MyChesCo
Mobile-health Network Solutions Receives Nasdaq Delinquency Notice for Minimum Bid Price Requirement - Vancity Buzz
High ROE & high ROCE multibagger stock in focus as company bags pilot export orders worth Rs 2,40,00,000 from clients in Europe, Middle East and USA - Dalal Street Investment Journal
A phone camera as health screening device? Healthtech agency’s new home displays innovations - The Straits Times
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by State of New Jersey Common Pension Fund D - Defense World
Global Electrotherapy System Research Report 2024: A $1.65 Billion Market by 2030 - GlobeNewswire Inc.
Exploring Opportunities in the Muscle Stimulation Devices - openPR
Muscle Stimulator Market Statistical Forecast, Trade Analysis - openPR
NeuroMetrix (STU:NLZ0) Shares Outstanding (EOP) : 2.02 Mil (As of Jun. 2024) - GuruFocus.com
NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com - Defense World
NeuroMetrix continues strategic review to boost value - Investing.com India
NeuroMetrix stock plunges to 52-week low of $2.66 By Investing.com - Investing.com Canada
NeuroMetrix Reiterates its Review of Strategic Alternatives - StockTitan
NeuroMetrix stock plunges to 52-week low of $2.66 - Investing.com
NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript - Seeking Alpha
NeuroMetrix Second Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.56 loss in 2Q 2023) - Yahoo Finance
Smart Medical Devices Market SWOT and PESTAL Analysis | 2032 - WICZ
Muscle Stimulation Devices Market Detailed Size Estimates - openPR
NURO Stock Earnings: NeuroMetrix Reported Results for Q2 2024 - MSN
NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options - StockTitan
NeuroMetrix reports Q2 revenue $769,148 vs. $1.66M last year - TipRanks
NeuroMetrix (NURO) Scheduled to Post Earnings on Tuesday - Defense World
Finanzdaten der Neurometrix Inc-Aktie (NURO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):